Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Reports $29.3M in Revenues

NEW YORK, Oct. 15 (GenomeWeb News) - Molecular Devices of Sunnyvale, Calif., yesterday reported revenues of $29.3 million for the third quarter ending Sept. 30, compared to $26 million for the same period in 2002.

 

The company had net income of $2.3 million for the period, compared to $1.8 million for the year-ago quarter, while spending $4.65 million on research and development, compared to $4.61 million for the same period in 2002.

 

The firm reported $102 million in total assets, including $42 million in cash and cash equivalents for the quarter, compared to $105 million in total assets and $44 million in cash and cash eqivalents for the same period a year ago.

 

In a statement, the firm said it expects revenues of $32 million to $34 million for the fourth quarter, and $114 million to $116 million for the year.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.